The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management

CS Foster, S Kothari, SD Anesi, AT Vitale, D Chu… - Survey of …, 2016 - Elsevier
Ocular inflammatory disease is a leading cause of vision loss worldwide. Uveitis
encompasses a wide spectrum of pathology, both with respect to its etiology and the …

Pharmacotherapy for uveitis: current management and emerging therapy

RJ Barry, QD Nguyen, RW Lee, PI Murray… - Clinical …, 2014 - Taylor & Francis
Uveitis, a group of conditions characterized by intraocular inflammation, is a major cause of
sight loss in the working population. Most uveitis seen in Western countries is noninfectious …

The TFOS International Workshop on Contact Lens Discomfort: report of the management and therapy subcommittee

EB Papas, JB Ciolino, D Jacobs… - … & visual science, 2013 - iovs.arvojournals.org
The aim of the subcommittee was to review published evidence and current practice in the
management and treatment of contact lens–related discomfort (CLD) in order to present an …

Outcome of tocilizumab treatment in refractory ocular inflammatory diseases

S Silpa‐archa, M Oray, JM Preble… - Acta …, 2016 - Wiley Online Library
Purpose To report the outcomes of tocilizumab treatment for refractory ocular inflammatory
diseases. Methods A retrospective case series of 17 patients (28 eyes) diagnosed with …

[HTML][HTML] Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline

A Arman, DD Demirseren, T Takmaz - International journal of …, 2015 - ncbi.nlm.nih.gov
AIM To compare the effectiveness of topical cyclosporine A emulsion with that of oral
doxycycline for rosacea associated ocular changes and dry eye complaints. METHODS One …

Noninfectious immune-mediated uveitis and ocular inflammation

J Pan, M Kapur, R McCallum - Current allergy and asthma reports, 2014 - Springer
Noninfectious uveitis encompasses a diverse group of ocular inflammatory disorders that
share an underlying immune etiology and may be associated with systemic disease or …

Certolizumab pegol, a new anti-TNF-α in the armamentarium against ocular inflammation

V Llorenç, M Mesquida… - Ocular immunology …, 2016 - Taylor & Francis
Purpose: To study the efficacy and tolerance of certolizumab pegol (CZP) in active uveitis.
Methods: Retrospective case series at 4 referral centers. Patients treated with CZP for active …

World workshop on oral medicine VI: a systematic review of the treatment of mucous membrane pemphigoid

J Taylor, R McMillan, M Shephard, J Setterfield… - Oral surgery, oral …, 2015 - Elsevier
Objective To determine the efficacy and safety of interventions for mucous membrane
pemphigoid (MMP). Study Design We conducted a systematic review from 2003 to 2013 …

[HTML][HTML] Efficacy and safety of intravitreal sirolimus for noninfectious uveitis of the posterior segment: results from the Sirolimus Study Assessing Double-Masked …

PT Merrill, WL Clark, AS Banker, C Fardeau, P Franco… - Ophthalmology, 2020 - Elsevier
Purpose To evaluate the efficacy and safety of intravitreal sirolimus in the management of
noninfectious uveitis of the posterior segment (NIU-PS). Design Combined analysis of 2 …

Matching for Human Leukocyte Antigens (HLA) in corneal transplantation–To do or not to do

TH Van Essen, DL Roelen, KA Williams… - Progress in retinal and …, 2015 - Elsevier
As many patients with severe corneal disease are not even considered as candidates for a
human graft due to their high risk of rejection, it is essential to find ways to reduce the …